Latin America T-cell Therapy Market Size & Outlook
Latin America t-cell therapy market, 2018-2028 (US$M)
Related Markets
Latin America t-cell therapy market highlights
- The Latin America t-cell therapy market generated a revenue of USD 70.5 million in 2021.
- The market is expected to grow at a CAGR of 7% from 2022 to 2028.
- In terms of segment, commercialized was the largest revenue generating modality type in 2021.
- Research is the most lucrative modality type segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2022 to 2028.
Latin America data book summary
| Market revenue in 2021 | USD 70.5 million |
| Market revenue in 2028 | USD 113.0 million |
| Growth rate | 7% (CAGR from 2021 to 2028) |
| Largest segment | Commercialized |
| Fastest growing segment | Research |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Research, Commercialized |
| Key market players worldwide | Novartis AG ADR, Merck KGaA, Gilead Sciences Inc, Adaptimmune Therapeutics PLC ADR, Bluebird bio Inc, Sorrento Therapeutics Inc, Fate Therapeutics Inc, Pfizer Inc, Amgen Inc, Bristol-Myers Squibb Co |
Other key industry trends
- In terms of revenue, Latin America region accounted for 1.1% of the global t-cell therapy market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,113.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
T-cell Therapy Market Scope
T-cell Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America t-cell therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to t-cell therapy market will help companies and investors design strategic landscapes.
Commercialized was the largest segment with a revenue share of 94.04% in 2021. Horizon Databook has segmented the Latin America t-cell therapy market based on research, commercialized covering the revenue growth of each sub-segment from 2018 to 2028.
The Latin America T-cell therapy market is expected to grow at a lucrative CAGR during the forecast period owing to the presence of emerging economies in the region. Although no T-cell therapies have been approved in the Latin American region, rising R&D is anticipated to fuel the demand for these therapies. Rising pharmaceutical investments in the region is further expected to boost market growth.
Reasons to subscribe to Latin America t-cell therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America t-cell therapy market databook
-
Our clientele includes a mix of t-cell therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America t-cell therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America t-cell therapy market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America t cell therapy market size, by country, 2018-2028 (US$M)
Latin America T-cell Therapy Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
